arrow
Back
G

Genentech, Inc.

Scholars175
Papers33
Citations0
Related Papers (26)
Publication Date
Final analysis of the FeDeriCa phase III study: long-term efficacy, safety and pharmacokinetics of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection, plus chemotherapy, in HER2-positive early breast cancer
err2026-07-31
err0
errOAAI
errC. Jackisch; S.-A. Im; A. Mattar; R. Colomer; D. Stroyakovskiy; Z. Nowecki; M. De Laurentiis; J.-Y. Pierga; K.H. Jung; C. Schem; S. Heeson; I. Yan; B. Wang; E. Restuccia; A.R. Tan
errShare
errSave
Self-interaction nanoparticle spectroscopy predicts high-concentration viscosity of therapeutic IgG1 antibodies
errmAbs
IF7.3
err2026-07-30
err0
errOAAI
errSantosh Kumar Paidi; Julissa Ibrahim; Kateryna Stepurska; Jonathan Zarzar; Saeed Izadi; Erina Rude; Steven Luu; Daniel Kovner; Kelly O’Connor; Karenna Bol; Shrenik Mehta; Nisana Andersen; Nicole Stephens; Emily Makowski; Joel Heisler; Trevor Swartz; Paul J. Carter; Tomasz Baginski
errShare
errSave
A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B-Cell Lymphoma
err2026-07-28
err0
errOAAI
errJulio C. Chavez; Mariana Bastos-Oreiro; Catherine Diefenbach; Izidore S. Lossos; Nirav Shah; Sarit Assouline; Adam J. Olszewski; Seema Naik; Nilanjan Ghosh; Song Pham; Michael C. Wei; Connie Batlevi; Iris To; Wahib Ead; Sneha Makadia; Elicia Penuel; Jing Jing; Lihua E. Budde
errShare
errSave
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial
err2026-07-22
err0
errOAAI
errAdam D. Cohen; Joshua Richter; Suzanne Trudel; Alexander Lesokhin; Jacob P. Laubach; Sheeba K. Thomas; Simon J. Harrison; Luciano J. Costa; Andrew Spencer; Rafael Fonseca; Peter A. Forsberg; Jesus G. Berdeja; Rayan Kaedbey; Nizar J. Bahlis; Paula Rodriguez-Otero; Maria-Victoria Mateos; Tulika Tyagi; Divya Samineni; Wenyu Liu; Rin Nakamura; Voleak Choeurng; Chihunt Wong; James Cooper; Amrita Krishnan
errShare
errSave
Development of a Second-Generation Stereoselective Manufacturing Process for a Key N-Hydroxyamidine Intermediate of GDC-6599 Enabled by Data Science and Mechanistic Understanding
err2026-06-29
err0
PREAI
errJacob C. Timmerman; Allen Y. Hong; Kurt Püntener; Anna-Lena Glass; Sandro Tonazzi; Katarzyna A. Piechowicz; Maud Guillemot-Plass; José G. Napolitano; Breanna Conklin; Haiming Zhang; Francis Gosselin
errShare
errSave
Low Rates of Fibrosis in Eyes Treated with the Port Delivery Platform with Ranibizumab or with Monthly Ranibizumab in the Archway Trial
err2026-06-08
err0
errOAAI
errUsha Chakravarthy; Chui Ming Gemmy Cheung; Giovanni Staurenghi; SriniVas Sadda; Robyn Guymer; Glenn J. Jaffe; Christine A. Curcio; Nancy M. Holekamp; Isabel Bachmeier; Mahnaz Parian Scherb; Steven Blotner; Mel Rabena; Melina Cavichini Cordeiro; Beatriz G. Armendariz; Madeleine S. Kanku; Dominic Heinrich
errShare
errSave
Assessing Contribution of Effect in Oncology Combination Therapies: Lessons Learned to Inform and Optimize Future Registrational Trial Designs
err2026-06-03
err0
errOAAI
errHillary Andrews, PhD; Raja Agnihotram, MS; Gideon Blumenthal, MD; Julie Bullock, PharmD; Grace Collins, MS; Gary J Doherty, PhD; Anna F Farago, MD PhD; Yuko Ishii, PhD; Sreeneeranj Kasichayanula, PhD; Michael LeBlanc, PhD; Elena Levi-D'Ancona, PhD; Chunze Li, PhD; Karen McCullough, PhD; P K Morrow, MD; Bernat Navarro, PhD; Punam Sandhu, PhD; Sujay Shah, MD; Elad Sharon, MD; Zhen Su, MD; Carol Vallett, EdD; Yolanda Villalobos, MBA; Jeff D Allen, PhD; Mark D Stewart, PhD
errShare
errSave
Characterizing Antibody-Drug Conjugates with High Molecular Heterogeneity by Native Direct Mass Technology
err2026-06-02
err0
PREAI
errPhillip Y. Chu; Keely E. Fuller; Summer Baker Dockrey; Isabel Wang; Cheng-Wei Lin; Lizzie P. Harmon; Daojing Wang; Philip D. Compton; Jared O. Kafader; Neil L. Kelleher; Thomas H. Pillow; Jonathan L. Josephs; John C. Tran; Rachel Liuqing Shi
errShare
errSave
A Phase Ib Study of Efmarodocokin Alfa, an Interleukin-22 Agonist, in Combination with Standard of Care, in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
err2026-06-01
err0
errOAAI
errShukaib Arslan; Corey Cutler; Amin Alousi; Mehdi Hamadani; Sunil H. Abhyankar; Iskra Pusic; Maureen Ross; Gary Schiller; Ajit Dash; Wenyi Liu; Yanke Yu; Annemarie Lekkerkerker; Chin Wong; Melicent C. Peck
errShare
errSave
Developing Predictive Models by Sharing Predictions – An Investigation of a Federated Learning Approach for ADMET Predictions
err2026-05-29
err0
PREAI
errRajarshi Guha; Wenyi Wang; Edward Price; Barun Bhhatarai; Majdi Hassan; Anthony DiFranzo; Christopher Keefer; Nathaniel Woody; Fabio Broccatelli; Susanne Winiwarter; Ling He; Darren V. S. Green; Christopher D. Edwards; Harutoshi Kato; Yohei Kosugi; Prashant Desai
errShare
errSave
Development of a High-Throughput Experimentation Workflow for Photochemical Reaction Screening
err2026-05-28
err0
PREAI
errNam Nguyen; Colin Masui; Adam Childs; Andrew Barlow; Tao Chen; Malcolm P. Huestis
errShare
errSave
Optimization Leading to a Potent and Selective Cbl-b Inactive-State Inhibitor That Demonstrated In Vivo Efficacy
err2026-05-27
err0
PREAI
errJun Liang; Michael J. Lambrecht; Malcolm P. Huestis; Bingyan Zhu; Lisa M. Barton; Georgette M. Castanedo; Peter Man-Un Ung; Robin Larouche-Gauthier; Araz Jakalian; Jean-Philippe Leclerc; Arun Yadav; Pouyan Haghshenas; Samuel Aubert-Nicol; Hossein Ismaili; Liang Zhao; Melissa Leblanc; Hugo de Almeida; Qiuyue Wang; Thomas Garner; Sophia Tan; Madeleine S. Prangley; Jodie Pang; Jeremy M. Murray; Christine Yu; Peter L. Hsu; Sascha Rutz; Isabel Ishizuka; Haochu Huang; Chan Gao; Min Chen; Liz Mutter-Rottmayer; Satoko Kakiuchi-Kiyota; Dennis H. Leung; Ponien Kou; Linda Bao; Xiaojing Wang
errShare
errSave
Safety analyses of the INAVO120 randomised phase III trial of inavolisib or placebo with palbociclib–fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative, endocrine-resistant advanced breast cancer
err2026-05-27
err0
errOAAI
errS.-A. Im; K. Kalinsky; K.L. Jhaveri; S. Loibl; N. Turner; C. Saura; P. Schmid; S. Loi; E. Hamilton; N. Karadurmus; S. Wang; A.A. Awan; E.M. Ciruelos; C.-F. Chung; E. Thanopoulou; N. Shankar; S. Lim; Y. Jin; C. Song; D. Juric
errShare
errSave
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathway
err2026-05-27
err0
errOAAI
errY. Matsubara; M. Wakabayashi; W. Okamoto; T. Kato; T. Esaki; K. Kato; Y. Komatsu; T. Masuishi; T. Nishina; H. Bando; T. Misumi; M. Fukui; S. Matsuda; Y. Ikeda; J. Malato; K. Schulze; R. Price; A. Sato; T. Yoshino; Y. Nakamura
errShare
errSave
Characterization of Lysosomal Hydrolases and Transporters and Their Age-Dependent Variability: Relevance to Drug Metabolism and Transport of Small Molecule and Biologic Drugs
err2026-05-26
err0
errOAAI
errDarshak Gadara; Dilip Kumar Singh; Sandhya Subash; Guihua Yue; Deepak Ahire; Chris Bohl; Maciej Czerwinski; Stephanie Helmstetter; Scott Heyward; Robert S. Jones; Cyrus Khojasteh; Ryota Kikuchi; Priyanka Kulkarni; Bin Ma; Bernard Murray; Chris Seib; Bill Smith; David M. Stresser; Mitchell E. Taub; Ting Wang; Bhagwat Prasad
errShare
errSave
Biotransformation research advances—2025 year in review
err2026-05-25
err0
PREAI
errLionel Cheruzel; Upendra A. Argikar; Pietro Brunetti; Maria Chatzopoulou; Luying Chen; Sungjoon Cho; Deepika Dhaware; Carley J. S. Heck; Chandrashekhar Honrao; S. Cyrus Khojasteh; Jed N. Lampe; Jakob Lang; Bin Ma; Shuguang Ma; Karoline Rehm; Jessica A. Rowley; Herana Kamal Seneviratne; Hyeonglim Seo; Lloyd Wei Tat Tang; Yue-Ting Wang; Caroline Wei
errShare
errSave
Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicity
err2026-05-22
err0
errOAAI
errYvonne T. Kschonsak; Wei-Ching Liang; Joyce Chan; David Kan; Thao Nguyen; Karen Ruiz; Yee-Seir Kee; Wen-Ting K. Tsai; Hongkang Xi; Marina Moskalenko; Travis Morgenstern; Aurelie Herault; Lauriane Cabon; Ryo Okuda; Scott S. Stawicki; Jocelyn Chan; Matthew Grimmer; Diego Ellerman; James Mondo; Catherine F. Ruff; Gabriele Schaefer; Udi Segal; Robert Piskol; Nicholas J. Agard; Laetitia Comps-Agrar; Felipe de Sousa e Melo; James T. Koerber
errShare
errSave
Large-Scale Collaborative Assessment of Binding Free Energy Calculations for Drug Discovery Using OpenFE
err2026-05-21
err0
PREAI
errHannah M. Baumann; Joshua T. Horton; Michael M. Henry; Alyssa Travitz; Benjamin Ries; Richard J. Gowers; David W. H. Swenson; Iván Pulido; Dominic Rufa; David L. Dotson; Nupur Bansal; Joseph P. Bluck; Howard Broughton; Kira A. Campbell; Lili Cao; Benedikt Frieg; Vytautas Gapsys; Hendrik Göddeke; Marco Klähn; Sirish Kaushik Lakkaraju; Stephanie M. Linker; Thomas Löhr; Aniket Magarkar; Sergio Pérez-Conesa; Hans E. Purkey; Hayk Saribekyan; Jenke Scheen; Christina E. M. Schindler; Thomas Steinbrecher; Chaya D. Stern; Patricia Suriana; William C. Swope; Gary Tresadern; Lev Tsidilkovski; Binqing Wei; Alexander H. Williams; Yao Wu; Ivy Zhang; John D. Chodera; James R. B. Eastwood; David L. Mobley; Irfan Alibay
errShare
errSave